PAP-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases

Materials and methods. The study included 119 patients with obstructive sleep apnea (OSA) and cardiovascular diseases (CVD) who were followed up at the National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation in the period from 2012 to 2020, and have been re...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Oksana O. Mikhailova, Eugenia M. Elfimova, Aleksander Yu. Litvin, Irina E. Chazova
Formato:	article
Lenguaje:	RU
Publicado:	IP Morozov P.V. 2021
Materias:	positive airway pressure therapy adherence obstructive sleep apnea Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/7e2eed3757344cd1b45bf3f115305c6f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7e2eed3757344cd1b45bf3f115305c6f
record_format	dspace
spelling	oai:doaj.org-article:7e2eed3757344cd1b45bf3f115305c6f2021-11-30T16:09:16ZPAP-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases2075-082X2542-218910.26442/2075082X.2020.4.200529https://doaj.org/article/7e2eed3757344cd1b45bf3f115305c6f2021-02-01T00:00:00Zhttps://syst-hypertension.ru/2075-082X/article/viewFile/60281/43450https://doaj.org/toc/2075-082Xhttps://doaj.org/toc/2542-2189Materials and methods. The study included 119 patients with obstructive sleep apnea (OSA) and cardiovascular diseases (CVD) who were followed up at the National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation in the period from 2012 to 2020, and have been receiving positive airway pressure (PAP) therapy (93 men, 78.2%). The median follow-up was 3.0 years [1.5; 5.0]. The adherence criteria were the following: the usage of the PAP device for at least 71% of nights a year, and at least 4 hours per night. Results. 64.3% of patients met the criteria for adherence to PAP therapy (use more than 4 hours/night, more than 71% of nights). The adherent patients were older (64.0 years [58.5; 68.0] versus 59.0 years [53.0; 65.0] resp., p=0.03) and had a higher apnea-hypopnea index AHI (47.7 events/h [37.5; 64.4] versus 38.2 events/h [30.4; 52.7] resp., p=0.04). Patients with stage III of hypertension were using a PAP device every night significantly less (3.4 h/night [1.1; 3.6] versus 6.3 h/night [5.3; 7.4] respectively, p=0.00) in comparison with patients with hypertension stages III. The adherence of patients with or without coronary artery disease (CAD) and paroxysmal atrial fibrillation (AF) did not differ. There was no significant difference in the incidence of stage III hypertension, CAD, and permanent AF between the groups of adherent and non-adherent to PAP therapy patients. Conclusion. 63.4% of patients with CVD were adherent to PAP therapy. Adherent patients were older and had a higher AHI. Patients with stage III hypertension were worse adherent to PAP therapy in comparison with patients with hypertension of lesser stages. The CVDs course in adherent and non-adherent patients did not differ.Oksana O. MikhailovaEugenia M. ElfimovaAleksander Yu. LitvinIrina E. ChazovaIP Morozov P.V.articlepositive airway pressure therapy adherenceobstructive sleep apneaDiseases of the circulatory (Cardiovascular) systemRC666-701RUСистемные гипертензии, Vol 17, Iss 4, Pp 37-43 (2021)
institution	DOAJ
collection	DOAJ
language	RU
topic	positive airway pressure therapy adherence obstructive sleep apnea Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	positive airway pressure therapy adherence obstructive sleep apnea Diseases of the circulatory (Cardiovascular) system RC666-701 Oksana O. Mikhailova Eugenia M. Elfimova Aleksander Yu. Litvin Irina E. Chazova PAP-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases
description	Materials and methods. The study included 119 patients with obstructive sleep apnea (OSA) and cardiovascular diseases (CVD) who were followed up at the National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation in the period from 2012 to 2020, and have been receiving positive airway pressure (PAP) therapy (93 men, 78.2%). The median follow-up was 3.0 years [1.5; 5.0]. The adherence criteria were the following: the usage of the PAP device for at least 71% of nights a year, and at least 4 hours per night. Results. 64.3% of patients met the criteria for adherence to PAP therapy (use more than 4 hours/night, more than 71% of nights). The adherent patients were older (64.0 years [58.5; 68.0] versus 59.0 years [53.0; 65.0] resp., p=0.03) and had a higher apnea-hypopnea index AHI (47.7 events/h [37.5; 64.4] versus 38.2 events/h [30.4; 52.7] resp., p=0.04). Patients with stage III of hypertension were using a PAP device every night significantly less (3.4 h/night [1.1; 3.6] versus 6.3 h/night [5.3; 7.4] respectively, p=0.00) in comparison with patients with hypertension stages III. The adherence of patients with or without coronary artery disease (CAD) and paroxysmal atrial fibrillation (AF) did not differ. There was no significant difference in the incidence of stage III hypertension, CAD, and permanent AF between the groups of adherent and non-adherent to PAP therapy patients. Conclusion. 63.4% of patients with CVD were adherent to PAP therapy. Adherent patients were older and had a higher AHI. Patients with stage III hypertension were worse adherent to PAP therapy in comparison with patients with hypertension of lesser stages. The CVDs course in adherent and non-adherent patients did not differ.
format	article
author	Oksana O. Mikhailova Eugenia M. Elfimova Aleksander Yu. Litvin Irina E. Chazova
author_facet	Oksana O. Mikhailova Eugenia M. Elfimova Aleksander Yu. Litvin Irina E. Chazova
author_sort	Oksana O. Mikhailova
title	PAP-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases
title_short	PAP-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases
title_full	PAP-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases
title_fullStr	PAP-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases
title_full_unstemmed	PAP-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases
title_sort	pap-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases
publisher	IP Morozov P.V.
publishDate	2021
url	https://doaj.org/article/7e2eed3757344cd1b45bf3f115305c6f
work_keys_str_mv	AT oksanaomikhailova paptherapyadherenceinpatientswithobstructivesleepapneaandcardiovasculardiseases AT eugeniamelfimova paptherapyadherenceinpatientswithobstructivesleepapneaandcardiovasculardiseases AT aleksanderyulitvin paptherapyadherenceinpatientswithobstructivesleepapneaandcardiovasculardiseases AT irinaechazova paptherapyadherenceinpatientswithobstructivesleepapneaandcardiovasculardiseases
_version_	1718406453372387328

PAP-therapy adherence in patients with obstructive sleep apnea and cardiovascular diseases

Ejemplares similares